ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ARDT vs NHC // ALTMAN Z-SCORE & DEBT/EQUITY

Ardent Health Inc. (NYSE) VS. National HealthCare Corporation (NYSE) • 15-METRIC TALLY: ARDT 3 — NHC 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARDT VS. NHC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ARDT NHC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 10.50% 10.10% +0.40 ARDT /roic <GO>
EV/EBITDA & P/E Valuation — 20.5x — TIE /valuation <GO>
Free Cash Flow Yield — 4.47% — TIE /fcf-yield <GO>
Operating Margin — 8.50% — TIE /operating-margins <GO>
Net Profit Margin 2.10% 7.90% -5.80 NHC /net-margins <GO>
Revenue Growth (YoY) 6.00% 16.10% -10.10 NHC /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 1.16% -1.16 NHC /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — 6.61 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 8/9 -1.00 NHC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 57.6 35.1 +22.55 ARDT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 11.9x 23.3x -11.40 ARDT /forward-pe <GO>
Enterprise Scale & Market Cap $1.73B $3.32B -$1.59B NHC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ARDT REV NHC REV ARDT GROSS % NHC GROSS % ARDT FCF NHC FCF
FY 2025 $6.32B $1.52B — — $470.5M $148.6M
FY 2024 $5.97B $1.31B — — $315.0M $79.7M
FY 2023 $5.41B $1.14B — — $221.7M $111.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARDT // BETA —
NHC // BETA —